Similar drugsTo uncover
Dosage form: & nbsppowder effervescent for solution for oral administration
Composition:

1 the sachet contains:

active substances

paracetamol 650 mg;

ascorbic acid 250 mg;

caffeine - 30 mg;

dextromethorphan hydrobromide monohydrate 20.0 mg;

chlorphenamine maleate - 4.0 mg;

Excipients

sodium saccharinate, sodium cyclamate, orange flavor, silicon dioxide colloid, sodium carbonate, sodium hydrogen carbonate, citric acid.

Description:

From white to yellowish white, a homogeneous powder dissolves in water with the release of gas bubbles and the formation of a transparent or opalescent solution with the smell of orange.

Pharmacotherapeutic group:Means for elimination of symptoms of acute respiratory disease and "colds" (analgesic non-narcotic means + H1-histamine receptors blocker + psychostimulating agent + vitamin + antitussive opioid
ATX: & nbsp
  • Paracetamol in combination with psycholeptics
  • Pharmacodynamics:

    Combined drug used for "cold" diseases, the effect of which is due to its constituent components.

    Paracetamol - an analgesic-antipyretics, blocks cyclooxygenase mainly in the central nervous system, affecting the centers of pain and thermoregulation.Reduces the pain syndrome, which is observed in catarrhal diseases - sore throat, headache, muscle and joint pain, reduces high body temperature.

    Ascorbic acid replenishes vitamin C deficiency with "cold" diseases.

    Caffeine stimulates the psychomotor centers of the brain, increases the effect of analgesics, eliminates drowsiness and a sense of fatigue.

    Dextromethorphan is an antitussive remedy, close in strength to codeine. Increases the sensitivity threshold of the cough center of the medulla oblongata, without leading to the depression of the respiratory center, suppresses cough of any origin, eliminates the irritating effect of dry, unproductive cough. Has some sedative effect, does not have analgesic, narcotic and hypnotic effects.

    Chlorphenamine - a blocker of H1-histamine receptors, has an antiallergic effect, reduces the permeability of the vessels of the mucous membrane of the upper respiratory tract, eliminates tearing, itching in the eyes and nose.

    Pharmacokinetics:

    The study of the pharmacokinetics of Influblok was not performed.

    Indications:

    Symptomatic treatment of infectious and inflammatory diseases (acute respiratory viral infection, influenza) accompanied by fever, severe chills, body aches, headache and muscle pain, runny nose (including allergic), stuffy nose, sneezing.

    Contraindications:
    • Hypersensitivity to paracetamol and other components of the drug;
    • Portal hypertension;
    • Alcoholism;
    • Deficiency of the enzyme glucose-6-phosphate dehydrogenase;
    • Bronchial asthma;
    • Simultaneous administration of monoamine oxidase inhibitors (MAO);
    • Pregnancy;
    • Lactation period;
    • Age to 18 years.
    Carefully:Arterial hypertension; diabetes; chronic obstructive pulmonary disease; angle-closure glaucoma; severe liver or kidney disease, lung; difficulty urinating with benign prostatic hyperplasia; blood diseases; congenital hyperbilirubinemia (syndromes Gilbert, Dubin-Johnson and Rotor); erosive and ulcerative lesions of the gastrointestinal tract (in the phase of exacerbation).
    Pregnancy and lactation:

    The drug is contraindicated in pregnancy and lactation.

    Dosing and Administration:

    Inside. Dissolve the contents of the sachet in ½ a glass of hot water and a drink. The recommended dose for adults is 1 packet 3 times a day every 8 hours (no more than 3 doses in 24 hours).

    Take the drug should you see the first symptoms of the disease. As the symptoms disappear, stop taking the drug.

    The course of treatment should not exceed 5 days.

    If there is no relief of symptoms within 5 days after starting the drug, you should consult your doctor.

    Side effects:

    From the central nervous system: drowsiness, headache, dizziness, falling asleep, increased excitability, distracted attention, tremor, mydriasis, increased intraocular pressure, paresis of accommodation.

    From the cardiovascular system: increased blood pressure, tachycardia, ventricular extrasystole, cardialgia.

    From the digestive system: nausea, epigastric pain, decreased appetite, indigestion, dry mouth, constipation. With long-term use in large doses - a hepatotoxic effect, bleeding in the gastrointestinal tract.

    On the part of the hematopoiesis system: anemia, with prolonged use in large doses hemolytic anemia, aplastic anemia, methemoglobinemia, pancytopenia, thrombocytopenia, leukopenia, agranulocytosis.

    From the urinary system: urinary retention, with prolonged use in large doses - nephrotoxicity (renal colic, glucosuria, interstitial nephritis, papillary necrosis).

    Allergic reactions: skin rash, itching, hives, angioedema.

    Other: bronchoobstructive syndrome.

    Overdose:

    Symptoms

    Paracetamol: pallor of the skin, decreased appetite, nausea, vomiting; hepatonecrosis (the severity of necrosis due to intoxication directly depends on the degree of overdose). Toxic effect in adults is possible after taking more than 10-15 g of paracetamol: increased activity of "liver" transaminases, an increase prothrombin time (12-48 hours after administration); a detailed clinical picture of liver damage manifests itself after 1-6 days. Rarely, liver failure develops at a lightning speed and can be complicated by renal insufficiency (tubular necrosis).

    Dextromethorphan: nausea, vomiting, dizziness, drowsiness, visual impairment, inhibition, impaired coordination of motion, difficulty breathing.

    Caffeine: gastralgia, agitation, anxiety, agitation, motor anxiety, confusion, delirium, dehydration, tachycardia, arrhythmia, hyperthermia, frequent urination, headache, increased tactile or pain sensitivity, tremor or muscle twitching; nausea and vomiting, sometimes with blood; ringing in the ears, epileptic seizures (with acute overdose - tonic-clonic). Caffeine in doses of more than 300 mg / day (including against the background of the abuse of coffee - more than 4 cups of natural coffee of 150 ml) can cause anxiety, tremor, headache, confusion, extrasystole.

    Ascorbic acid: diarrhea, nausea, irritation of the mucous membrane of the gastrointestinal tract, flatulence, abdominal pain of a spastic nature, frequent urination, nephrolithiasis, insomnia, irritability, hypoglycemia.

    Chlorphenamine: nausea, vomiting, anorexia, dry mouth, dry nasal mucosa, abdominal pain or in the liver, heart rhythm disturbances (arrhythmias, bradycardia or tachycardia), in severe cases - liver failure.

    Treatment: gastric lavage in the first 6 hours, followed by the appointment of activated charcoal, laxatives. Symptomatic therapy. Maintain a balance of fluid and salts, ventilation and oxygenation; with epileptic seizures - intravenously diazepam, phenobarbital or phenytoin.

    Introduction of donors of SH groups and precursors of glutathione-methionine synthesis for 8-9 hours and acetylcysteine ​​for 12 hours after an overdose.

    The need for additional therapeutic measures (further introduction of methionine, intravenous injection of acetylcysteine) is determined depending on the concentration of paracetamol in the blood, as well as on the time elapsed after its administration.

    Naloxone is a specific antidote for dextromethorphan. In the case of respiratory depression and difficulty of coordination of movements, it is necessary to appoint naloxone and artificial ventilation.

    Interaction:

    Dextromethorphan increases the effects of MAO inhibitors, sedatives, ethanol.

    Amiodarone, fluoxetine, quinidine, by inhibiting the cytochrome P450 system, can increase the concentration of dextromethorphan in the blood.

    Ethanol enhances the sedative effect of chlorphenamine.

    With simultaneous use of chlorphenamine with antidepressants, antiparkinsonian, antipsychotic drugs and phenothiazine derivatives, the risk of urinary retention, dry mouth, constipation increases.

    When combined paracetamol reduces the effectiveness of uricosuric medicines and improves the effectiveness of indirect anticoagulants.

    When used simultaneously with paracetamol, the toxicity of chloramphenicol may be increased.

    The risk of hepatotoxic effects of paracetamol increases with the simultaneous administration of barbiturates, diphenin, carbamazepine, rifampicin, zidovudine and other inducers of microsomal liver enzymes.

    When used simultaneously with oral contraceptives, the excretion of paracetamol from the body is accelerated and its analgesic effect may decrease.

    With simultaneous application with metoclopramide, it is possible to increase the absorption of paracetamol and increase its concentration in the blood plasma.

    Special instructions:

    During the use of the drug should refrain from drinking alcohol, sleeping pills or anxiolytic drugs.

    It is necessary to exclude simultaneous reception of other preparations containing paracetamol, in connection with the content of the latter in the composition Influblok.

    Effect on the ability to drive transp. cf. and fur:

    During the use of the drug should be careful when dealing with potentially dangerous activities that require increased attention and speed of psychomotor reactions.

    Form release / dosage:

    Powder effervescent for solution for oral administration.

    Packaging:

    By 2,8 g in a bag of combined material (paper, aluminum foil, polyethylene).

    For 10 bags with instructions for use in a cardboard box.

    Storage conditions:

    In the dark place at a temperature of no higher than 30 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:On prescription
    Registration number:LSR-006030/10
    Date of registration:28.06.2010 / 26.08.2015
    Expiration Date:Unlimited
    The owner of the registration certificate:Pharmaceutical factory "POLFARMA" JSCPharmaceutical factory "POLFARMA" JSC Poland
    Manufacturer: & nbsp
    Representation: & nbspAKRIKHIN OJSC AKRIKHIN OJSC Russia
    Information update date: & nbsp26.10.2017
    Illustrated instructions
      Instructions
      Up